Inovia Bio

Startup

Inovia Bio is at the forefront of transforming drug development by merging advanced machine learning and data engineering with critical industry insights. Our platform, InovaSight, leverages the entirety of the scientific evidence base to enable drug developers to position their assets optimally from the outset.

It digitises early or late-stage assets to forecast therapeutic indications, linking each to a real-time evaluation of the competitive and clinical landscape. This ensures that Target Product Profile (TPP) and Clinical Development Plan (CDP) assumptions are made with unmatched precision, accuracy and speed.

Complementing InovaSight, our Real World Evidence (RWE) hub called InovaMine, allows RWE teams to analyse vast datasets efficiently and with unprecedent speed, the hub is able to ingest all sort of data set.
Through the use of a digital SAP, InovaMine ensures that RWE analyses are scientifically credible and that any database limitations are acknowledged. This enables RWE teams to pinpoint the most suitable use cases for their data, delivering swift value to stakeholders.

Our comprehensive approach not only streamlines the drug development process but also enhances its accuracy. Inovia Bio is dedicated to driving innovation within the drug development sector, leveraging the latest technology and deep industry knowledge to improve efficiency and effectiveness. Our commitment to accuracy and transparency is evident in our platforms, which provide reliable insights, facilitating a more effective drug development process and contributing to the quicker introduction of new therapies to the market.